• Notifications
    This feature only available to registered users.
  • Alerts
    This feature only available to registered users
  • Welcome Guest!
  • Login Signup

Stock [ BUY ] / [ SELL ] Trading Strategies
. [ Show Details ]


Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





YES
     
PFE [ Pfizer Inc ]
Last Trade 33.83 Date 7/11/2020
Change % 1.11 % Price Change 0.37
Open 33.66 52 Week High 43.23
High 34.04 52 Week Low 27.88
Low 33.485 Type stock
Volume 23205943 Average Volume 22489706
Prev Close 33.46 Stock Exchange NYSE
Bid 33.81 Ask 33.85
Bid Size 7 Ask Size 337
1st Yr Estimated EPS Growth 0.3133 2nd Yr Estimated EPS Growth 0.0813
2 Years Forward Earning Yield 0.0905 2 Years Forward PE Ratio 11.0556
2 Years EV/Forward EBIT 12.82 2 Years EV/Forward EBITDA 10.0787
Book Value per Share 11.7031 Book Value Yield 0.3459
Buy Back Yield 0.0 CAPE Ratio 18.439
Cash Return 0.0567 Cash Flow per Share 2.486
Cash Flow Yield 0.0735 Dividend Rate 1.52
Dividend Yield 4.37 5 Year Dividend Yield 0.0357
Earning Yield 0.0828 EV/EBIT 12.1969
EV/EBITDA 9.3712 EV / Free Cash Flow 19.8992
EV / Forward EBIT 14.5169 EV / Forward EBITDA 11.0538
EV / Forward Revenue 4.7178 EV / Pre Tax Income 13.3307
EV / Revenue 4.5376 EV / Total Asset 1.382
Expected Dividend Growth Rate 0.027 Free Cash Flow per Share 2.048
Free Caash Flow Ratio 16.518921 Free Cash Flow Yield 0.0605
Forward Calculation Style Annual Forward Dividend Yield 0.0449
Forward Earning Yield 0.0837 Forward PE Ratio 11.9474
Forward Return on Asset 0.0945 Forward Return on Equity 0.2418
Normalized PE Ratio 15.699236 Payout Ratio 0.5214
PB Ratio 2.890677 PB Ratio 10 Year Growth 0.076808
PB Ratio 3 Year Growth 3.392124 Cash Ratio 3 Year Average 1660.2176
Price to Cash Flow Ratio 13.608113 PEG Payback 8.7077
PEG Ratio 2.5434 PE Ratio 12.082143
PE Ratio 10 Year Average 20.25339 PE Ratio 10 Year Growth -0.015093
PE Ratio 10 Year High 33.61 PE Ratio 10 Year Low 9.553977
PE Ratio 1 Year Avg 14.200939 PE Ratio 1 Year High 22.097436
PE Ratio 1 Year Low 9.926829 PE Ratio 3 Year Avg 16.103113
PE Ratio 5 Year Avg 20.734793 PE Ratio 5 Year High 33.61
PE Ratio 5 Year Low 9.553977 Free Cash Flow Ratio 10 Year Growth -0.012534
Free Cash Flow Ratio 3 Year Avg 17.289454 Price Change 1 Month 1.034557
Price to Cash Ratio 18.156524 Price / EBITDA 7.779314
Price to Sales Ratio 3.76681 Price to Sales Ratio 10 Year Growth 0.074853
Price to Sales Ratio 3 Year Avg 4.284951 Price to Sales Ratio 5 Year Avg 20.734793
Sale per Share 8.9811 Sales Yield 0.2655
Sustainable Growth Rate 0.1221 Tangible Book Value per Share -5.0329
Tangible Book Value per Share 3 year Avg -6.2009 Tangible Book Value per Share 5 year Avg -6.0446
Total Asset per Share 29.9444 Total Yield 0.0437
Working Capital per Share 0.1527 Working Capital per Share 3 Year Avg 1.1943
Working Capital per Share 5 Year Avg 1.3955 Beta 0.601092
Company Profile

Pfizer Inc., a biopharmaceutical company, engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. The company?s Biopharmaceutical segment offers products in the areas of primary care, specialty care, established products, emerging markets, and oncology customer-focused units. Its principal products include Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Revatio for pulmonary arterial hypertension; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimer?s disease. This segment?s products also comprise Celebrex for osteoarthritis and rheumatoid arthritis and acute pain; Zyvox for Gram-positive pathogens; Viagra for erectile dysfunction; Detrol/ Detrol LA for overactive bladder; Sutent for advanced renal cell carcinoma; Xalatan for open-angle glaucoma and ocular hypertension; Genotropin for growth disorders; Vfend, an antifungal agent; Effexor for depressive disorders; Prevnar/Prevnar7 for invasive pneumococcal disease; Enbrel for rheumatoid arthritis; Protonix, proton pump inhibitor for erosive esophagitis; and Spiriva for breathing problems. The company?s Diversified segment offers animal health products, which include antibiotics, anti-inflammatories, antiemetics, parasiticides, and vaccines; consumer healthcare products comprising dietary supplements, pain management, respiratory, and topicals/gastro-intestinal products; Nutrition products; and Capsugel products that include gelatin, liquid, softgel, non-animal, and fish gelatin capsules. Pfizer Inc. serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. It has a strategic alliance with Acacia Living Inc. The company was founded in 1849 and is headquartered in New York, New York.